Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses

Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses

Abstract Background Shorter duration of symptoms before remdesivir has been associated with better outcomes. Our goal was to evaluate variables associated with the need of ICU admission in a cohort of hospitalized patients for COVID-19 under remdesivir including the period from symptoms onset to rem...

書誌詳細
主要な著者:	Rodrigo Alonso-Navarro, Margarita Ramírez, Mar Masiá, Roger Paredes, Rocío Montejano, Marina Povar-Echeverria, Jordi Carratalà, Miguel Salavert, Enrique Bernal, Carlos Dueñas, Juan Flores, Francisco Fanjul, Isabel Gutiérrez, Verónica Rico, Lourdes Mateu, Julen Cadiñanos, Juan Berenguer, Alex Soriano
フォーマット:	論文
言語:	English
出版事項:	BMC 2023-05-01
シリーズ:	BMC Infectious Diseases
主題:	SARS-CoV-2 Remdesivir Days from symptoms onset ICU Progression
オンライン･アクセス:	https://doi.org/10.1186/s12879-023-08222-y

類似資料

Remdesivir administration for SARS-CoV-2 pneumonia in ICU and non-ICU patients: outcome and posttreatment differences — the Italian Military Hospital experience
著者:: Antonio Sabba, 等
出版事項: (2023-09-01)

The effect of remdesivir on mortality and the outcome of patients with COVID‐19 in intensive care unit: A case–control study
著者:: Mehran Amirizadeh, 等
出版事項: (2023-11-01)

The use of Remdesivir in pregnant women with COVID-19
著者:: Gulbanu Shaimerdenova, 等
出版事項: (2023-02-01)

Remdesivir for coronavirus 2019 (COVID-19): More promising but still unproven
著者:: Richard D. Shih, 等
出版事項: (2020-12-01)

Comparative therapeutic efficiency of remdesivir in COVID in a tertiary care center
著者:: Mahendra Munirathnam, 等
出版事項: (2021-01-01)

Publicaciones sobre hidroxicloroquina y remdesivir: actualización septiembre 2020
著者:: Flor álvarez de Toledo
出版事項: (2020-10-01)

Publicaciones sobre hidroxicloroquina y remdesivir: actualización septiembre 2020
著者:: Flor álvarez de Toledo
出版事項: (2020-10-01)

Use of Remdesivir in children with COVID-19: report of an Italian multicenter study
著者:: Lorenza Romani, 等
出版事項: (2024-02-01)

Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study
著者:: Emiel Leegwater, 等
出版事項: (2023-10-01)

Efficacy and Safety of Remdesivir in COVID-19 Positive Dialysis Patients
著者:: Batool Butt, 等
出版事項: (2022-01-01)

Remdesivir prescription in pregnant women infected with COVID-19: A report of compassionate use
著者:: Azam Zafarbakhsh, 等
出版事項: (2023-01-01)

Prominent bradycardia in a COVID-19 patient receiving Remdesivir: a case report
著者:: Sidhi Laksono Purwowiyoto, 等
出版事項: (2022-07-01)

Clinical outcomes and considerations in outpatient with COVID‐19 receiving remdesivir therapy
著者:: Zeinab Siami, 等
出版事項: (2024-07-01)

Remdesivir in a pregnant patient with COVID-19 pneumonia
著者:: Ranadheer Dande, 等
出版事項: (2021-01-01)

Critical reappraisal of remdesivir investigational trials in COVID-19
著者:: P. Brouqui, 等
出版事項: (2020-11-01)

Remdesivir versus standard-of-care for severe Coronavirus disease 2019 Infection: an analysis of 28-day mortality
著者:: Olender, Susan A., 等
出版事項: (2022)

Adverse effects of remdesivir for the treatment of acute COVID-19 in the pediatric population: a retrospective observational study
著者:: Abigail Schulz, 等
出版事項: (2024-02-01)

Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report
著者:: José A Gonzales-Zamora, 等
出版事項: (2020-08-01)

The journey of remdesivir: from Ebola to COVID-19
著者:: Joe Pardo, 等
出版事項: (2020-05-01)

Measuring the energy for the molecular graphs of antiviral agents: Hydroxychloroquine, Chloroquine and Remdesivir
著者:: Muhammad Haroon Aftab, 等
出版事項: (2024-01-01)

Mucocutaneous adverse effects of remdesivir and favipiravir in patients with Covid-19 infection: A systematic review
著者:: Pradeep Balasubramanian, 等
出版事項: (2022-01-01)

Recent knowledge in favor of remdesivir (GS-5734) as a therapeutic option for the COVID-19 infections
著者:: S. Saqrane, 等
出版事項: (2021-05-01)

Presentation of vitiligo in a case of COVID‐19 infection concomitant with receiving remdesivir
著者:: Farideh Beyki, 等
出版事項: (2024-03-01)

Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System
著者:: Concetta Rafaniello, 等
出版事項: (2021-06-01)

Clinical outcomes of using remdesivir in patients with moderate to severe COVID-19: A prospective randomised study
著者:: Lakshmi Mahajan, 等
出版事項: (2021-01-01)

Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics
著者:: Bhaswati Chatterjee, 等
出版事項: (2022-05-01)

Remdesivir – Current evidence & perspective in management of COVID-19 infection
著者:: Jyoti Bajpai, 等
出版事項: (2021-01-01)

Chitosan-Based Nanocarriers for Delivery of Remdesivir
著者:: Viktoria Milkova, 等
出版事項: (2023-08-01)

Remdesivir-induced severe hypoglycemia in an elderly man without diabetes: a case report
著者:: Yasunori Nagano, 等
出版事項: (2025-01-01)

Remdesivir for Hospitalized COVID-19 Patients in the United States: Optimization of Health Care Resources
著者:: Lianne Barnieh, 等
出版事項: (2023-05-01)

Hospital at home treatment with remdesivir for patients with COVID-19: real-life experience
著者:: Irene Pereta, 等
出版事項: (2023-02-01)

Remdesivir effects on COVID-19 infection in adult patients
著者:: Zena Hasan Sahib, 等
出版事項: (2022-01-01)

Clinical outcomes of remdesivir-treated COVID-19 patients in South Korea
著者:: Mi Yu, 等
出版事項: (2022-10-01)

Remdesivir in renal transplant patients with coronavirus disease 2019: An observational study
著者:: Muzamil Latief, 等
出版事項: (2022-01-01)

Safety and heart rate changes in Covid-19 patients treated with Remdesivir
著者:: Natale Daniele Brunetti, MD, PhD, 等
出版事項: (2021-11-01)

Mortality in SARS-CoV-2 Hospitalized Patients Treated with Remdesivir: A Nationwide, Registry-Based Study in Italy
著者:: Pierluigi Russo, 等
出版事項: (2022-05-01)

Synthesis of Radioisotope 14C Labelled Remdesivir
著者:: Zhi-yang YU, 等
出版事項: (2025-02-01)

Safety of Remdesivir and Tocilizumab in COVID-19 Treatment
著者:: Alexandra A. Taube, 等
出版事項: (2020-09-01)

Differential cytokine responses in hospitalized COVID-19 patients limit efficacy of Remdesivir
著者:: Chan, Yi-Hao, 等
出版事項: (2022)

Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab
著者:: Ivan Gentile, 等
出版事項: (2023-12-01)